Wm. Weightman et al., Drug therapy before coronary artery surgery: Nitrates are independent predictors of mortality and beta-adrenergic blockers predict survival, ANESTH ANAL, 88(2), 1999, pp. 286-291
Citations number
27
Categorie Soggetti
Aneshtesia & Intensive Care","Medical Research Diagnosis & Treatment
We conducted this study to evaluate whether there is an association between
preoperative drug therapy and in-hospital mortality in patients undergoing
coronary artery graft surgery. We collected data on 1593 consecutive patie
nts undergoing coronary artery surgery. The relative risk of in-hospital mo
rtality was determined by logistic regression with in-hospital mortality as
the dependent variable, and independent variables that included known risk
factors and preoperative cardioactive or antithrombotic drug treatment, i.
e., age; left ventricular function; left main coronary artery disease; urge
nt priority; gender; previous cardiac surgery; concurrent cardiovascular su
rgery; chronic lung disease; creatinine concentration; hemoglobin concentra
tion; diabetes; hypertension; cerebrovascular disease; recent myocardial in
farction; prior vascular surgery; number of arteries bypassed; and regular
daily treatment with beta-blockers, aspirin within 5 days, calcium antagoni
sts, angiotensin converting enzyme (ACE) inhibitors, digoxin, or warfarin.
In-hospital mortality was 3.3%. The relative risk of in-hospital mortality
(with 95% confidence intervals of the relative risk) associated with the fo
llowing drug treatments was: nitrates 3.8 (1.5-9.6), beta-blockers 0.4 (0.2
-0.8), aspirin within 5 days 1.0 (0.5-1.9), calcium antagonists 1.1 (0.6-2.
1), ACE inhibitors 0.8 (0.4-1.5), digoxin 0.7 (0.2-1.8), and warfarin 0.3 (
0.1-1.6). We conclude that in-hospital mortality is positively associated w
ith preoperative nitrate therapy and negatively associated with beta-adrene
rgic blocker therapy. A significant association between in-hospital mortali
ty and the preoperative use of calcium antagonists, ACE inhibitors, aspirin
, digoxin, and warfarin was not confirmed. Implications: We examined the as
sociation between common drug treatments for ischemic heart disease and sho
rt-term survival after cardiac surgery using a statistical method to adjust
for patients' preoperative medical condition. Death after surgery was more
likely after nitrate therapy and less likely after beta-blocker therapy.